These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 11782019)

  • 1. Peptide-pulsed splenic dendritic cells prime long-lasting CD8(+) T cell memory in the absence of cross-priming by host APC.
    Livingstone AM; Kuhn M
    Eur J Immunol; 2002 Jan; 32(1):281-90. PubMed ID: 11782019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help.
    Ontiveros F; Wilson EB; Livingstone AM
    Immunology; 2011 Apr; 132(4):549-58. PubMed ID: 21255009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ cytotoxic T-APC stimulate central memory CD8+ T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation, and IL-2 secretion.
    Xia D; Hao S; Xiang J
    J Immunol; 2006 Sep; 177(5):2976-84. PubMed ID: 16920933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.
    Umeshappa CS; Huang H; Xie Y; Wei Y; Mulligan SJ; Deng Y; Xiang J
    J Immunol; 2009 Jan; 182(1):193-206. PubMed ID: 19109150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
    Porgador A; Gilboa E
    J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens.
    Livingstone AM; Kuhn M
    Eur J Immunol; 1999 Sep; 29(9):2826-34. PubMed ID: 10508257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
    Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
    Front Immunol; 2018; 9():2775. PubMed ID: 30542351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells.
    Schulz O; Pennington DJ; Hodivala-Dilke K; Febbraio M; Reis e Sousa C
    J Immunol; 2002 Jun; 168(12):6057-65. PubMed ID: 12055214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen specificity acquisition of adoptive CD4+ regulatory T cells via acquired peptide-MHC class I complexes.
    Hao S; Yuan J; Xu S; Munegowda MA; Deng Y; Gordon J; Xing Z; Xiang J
    J Immunol; 2008 Aug; 181(4):2428-37. PubMed ID: 18684933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presenting B cells facilitate CD4 T cell cooperation resulting in enhanced generation of effector and memory CD4 T cells.
    Kroeger DR; Rudulier CD; Bretscher PA
    PLoS One; 2013; 8(10):e77346. PubMed ID: 24155947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells.
    Rubinstein MP; Kadima AN; Salem ML; Nguyen CL; Gillanders WE; Cole DJ
    J Immunol; 2002 Nov; 169(9):4928-35. PubMed ID: 12391205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly.
    Pham NL; Pewe LL; Fleenor CJ; Langlois RA; Legge KL; Badovinac VP; Harty JT
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12198-203. PubMed ID: 20616089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-cells specific for natural IgE peptides downregulate IgE production.
    Chen SS; Gong J; Yang YM; Oettgen H; Zanetti M
    Cell Immunol; 2005 Jan; 233(1):11-22. PubMed ID: 15913585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells.
    Lefrançois L; Altman JD; Williams K; Olson S
    J Immunol; 2000 Jan; 164(2):725-32. PubMed ID: 10623816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.
    Takahashi H; Nakagawa Y; Yokomuro K; Berzofsky JA
    Int Immunol; 1993 Aug; 5(8):849-57. PubMed ID: 8398980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of antitumor immunity using bone marrow-generated dendritic cells.
    Porgador A; Snyder D; Gilboa E
    J Immunol; 1996 Apr; 156(8):2918-26. PubMed ID: 8609412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of CD8+ T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC.
    Dalyot-Herman N; Bathe OF; Malek TR
    J Immunol; 2000 Dec; 165(12):6731-7. PubMed ID: 11120791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.